Prescription Drugs
US Congress 115th Congress
Budgeting for Opioid Addiction Treatment Act [S.523]
Budgeting for Opioid Addiction Treatment Act This bill amends the Internal Revenue Code, with respect to excise taxes on manufacturers, to impose a one cent per milligram fee on the sale of active opioids by the manufacturer, producer, or importer. The fee excludes prescription drugs used exclusively for the treatment of opioid addiction as part of a medically assisted treatment effort. The Department of Health and Human Services (HHS) must establish a program to provide rebates or discounts to cancer and hospice patients to ensure that they do
(continued...)
Sponsored by: Sen. Angus King
Read Twice And Referred To The Committee On Finance. on 03/02/2017
Spread the world
Gettr US Congress 115th Congress
DXM Abuse Prevention Act of 2017 [HB-1271]
DXM Abuse Prevention Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to: (1) require a retailer that sells certain drugs containing dextromethorphan (DXM) to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer, (2) establish other restrictions on the sale of over-the-counter drugs containing DXM, and (3) establish restrictions on the distribution of bulk DXM.
Sponsored by: Rep. Alcee Hastings
Referred To The Subcommittee On Health. on 03/17/2017
Spread the world
US Congress 115th Congress
Affordable and Safe Prescription Drug Importation Act [HB-1245]
Affordable and Safe Prescription Drug Importation Act
Sponsored by: Rep. Barbara Lee
Referred To The Subcommittee On Health. on 03/03/2017
Spread the world
US Congress 115th Congress
Affordable and Safe Prescription Drug Importation Act [S.469]
Affordable and Safe Prescription Drug Importation Act
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 02/28/2017
Spread the world
US Congress 115th Congress
OPEN Act Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017 [HB-1223]
OPEN Act Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to require the Department of Health and Human Services (HHS) to extend by six months the exclusivity period for a drug or biological product approved by the Food and Drug Administration (FDA) when the product is additionally approved to prevent, diagnose, or treat a new indication that is a rare disease or condition (also known as an orphan disease). HHS may revoke an extension if the application submitted
(continued...)
Sponsored by: Rep. Ted Poe
Referred To The Subcommittee On Health. on 03/03/2017
Spread the world
US Congress 115th Congress
Protecting Access to Care Act of 2017 [HB-1215]
Protecting Access to Care Act of 2017 This bill establishes provisions governing health care lawsuits where coverage for the care was provided or subsidized by the federal government, including through a subsidy or tax benefit. (Sec. 2) In general, the statute of limitations is three years after the occurrence of the breach or tort, three years after medical or health-care treatment for the injury is completed, or one year after the claimant discovers the injury, whichever occurs first. For a minor, the statute of limitations is three years after
(continued...)
Sponsored by: Rep. Steve King
Received In The Senate And Read Twice And Referred To The Committee On The Judiciary. on 06/29/2017
Spread the world
US Congress 115th Congress
Improving Transparency and Accuracy in Medicare Part D Spending Act [S.413]
Improving Transparency and Accuracy in Medicare Part D Spending Act This bill amends title XVIII (Medicare) of the Social Security Act to prohibit Medicare Prescription Drug Plan sponsors from retroactively reducing payment on clean claims submitted by pharmacies. (A "clean claim" is a Medicare claim that is free of defects such as incomplete documentation.)
Sponsored by: Sen. Susan Collins
Read Twice And Referred To The Committee On Finance. on 02/16/2017
Spread the world
US Congress 115th Congress
Health Savings Act of 2017 [HB-1175]
Health Savings Act of 2017 This bill amends the Internal Revenue Code, with respect to health savings accounts (HSAs), to: rename high deductible health plans as HSA-qualified health plans; allow spouses who have both attained age 55 to make catch-up contributions to the same HSA; make Medicare Part A (hospital insurance benefits) beneficiaries eligible to participate in an HSA; allow individuals eligible for hospital care or medical services under a program of the Indian Health Service or a tribal organization to participate in an HSA; allow members
(continued...)
Sponsored by: Rep. Barbara Comstock
Referred To The Subcommittee On Regulatory Reform, Commercial And Antitrust Law. on 03/16/2017
Spread the world
US Congress 115th Congress
SPARC Act Secondary Payer Advancement, Rationalization, and Clarification Act [HB-1122]
SPARC Act Secondary Payer Advancement, Rationalization, and Clarification Act This bill specifies recovery rules and timelines with respect to secondary claims responsibility under the Medicare prescription drug benefit. Current law specifies only that secondary payor provisions apply under the benefit in the same manner as they apply with respect to Medicare Advantage plans.
Sponsored by: Rep. David Rouzer
Referred To The Subcommittee On Health. on 03/01/2017
Spread the world
US Congress 115th Congress
Calling on the President to initiate renegotiation of the North American Free Trade Agreement (NAFTA) and further calling on the President to consider withdrawing the United States from NAFTA if the renegotiations are not satisfactorily completed within one year. [HR-132]
Calling on the President to initiate renegotiation of the North American Free Trade Agreement (NAFTA) and further calling on the President to consider withdrawing the United States from NAFTA if the renegotiations are not satisfactorily completed within one year. Expresses the sense of the House of Representatives that the President should: (1) initiate renegotiation of the North American Free Trade Agreement (NAFTA) by June 1, 2017; (2) ensure that specified provisions are included in the core text of such new agreement with Canada and Mexico that
(continued...)
Sponsored by: Rep. Barbara Lee
Referred To The Subcommittee On Trade. on 02/17/2017
Spread the world
US Congress 115th Congress
Health Savings Act of 2017 [S.403]
Health Savings Act of 2017 This bill amends the Internal Revenue Code, with respect to health savings accounts (HSAs), to: rename high deductible health plans as HSA-qualified health plans; allow spouses who have both attained age 55 to make catch-up contributions to the same HSA; make Medicare Part A (hospital insurance benefits) beneficiaries eligible to participate in an HSA; allow individuals eligible for hospital care or medical services under a program of the Indian Health Service or a tribal organization to participate in an HSA; allow members
(continued...)
Sponsored by: Sen. Marco Rubio
Read Twice And Referred To The Committee On Finance. on 02/15/2017
Spread the world
US Congress 115th Congress
Veteran Prescription Continuity Act [HB-1063]
Veteran Prescription Continuity Act This bill amends the National Defense Authorization Act for Fiscal Year 2016 to direct the Department of Veterans Affairs (VA) to furnish an individual who is transitioning from Department of Defense (DOD)- to VA-furnished medical treatment any pharmaceutical agent not included in the joint uniform formulary if a DOD health care provider determines that the pharmaceutical agent is critical for the transition. The VA shall furnish an individual with such pharmaceutical agent: (1) beginning when the individual enrolls
(continued...)
Sponsored by: Rep. Dina Titus
Referred To The Subcommittee On Health. on 03/03/2017
Spread the world
US Congress 115th Congress
Obamacare Replacement Act [HB-1072]
Obamacare Replacement Act This bill amends the Internal Revenue Code, the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Social Security Act to repeal certain provisions regarding health insurance, including: the requirement for individuals to maintain minimum essential coverage, limitations on insurers varying premiums by age or health status, requirements for health insurance to cover preexisting conditions, and the prohibition on lifetime or annual limits on benefits. The bill allows a refundable
(continued...)
Sponsored by: Rep. Alexander Mooney
Referred To The Subcommittee On Health. on 02/17/2017
Spread the world
US Congress 115th Congress
Improving Transparency and Accuracy in Medicare Part D Spending Act [HB-1038]
Improving Transparency and Accuracy in Medicare Part D Spending Act This bill amends title XVIII (Medicare) of the Social Security Act to prohibit Medicare Prescription Drug Plan sponsors from retroactively reducing payment on clean claims submitted by pharmacies. (A "clean claim" is a Medicare claim that is free of defects such as incomplete documentation.)
Sponsored by: Rep. Steve Russell
Sponsor Introductory Remarks On Measure. (cr E306) on 03/09/2017
Spread the world
US Congress 115th Congress
Compassionate Freedom of Choice Act of 2017 [HB-1020]
Compassionate Freedom of Choice Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to declare that nothing in that Act or in the Public Health Service Act prevents or restricts, and the Food and Drug Administration (FDA) may not prevent or restrict, the manufacture, importation, distribution, or sale of drugs or medical devices that are intended for terminally ill patients, have been the subject of a clinical trial, and have not been approved by the FDA. The FDA may not require the disclosure, collection, or reporting of certain
(continued...)
Sponsored by: Rep. H. Morgan Griffith
Referred To The Subcommittee On Health. on 02/17/2017
Spread the world
US Congress 115th Congress
Prescription Drug and Health Improvement Act of 2017 [S.348]
Prescription Drug and Health Improvement Act of 2017 This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate lower prices on behalf of Medicare and Medicare Advantage (MA) beneficiaries for covered prescription drugs that the CMS deems appropriate for negotiation based on: (1) program and per-beneficiary spending, (2) unit price increases over the preceding years, (3) initial launch price, (4) availability of similarly effective alternative treatments, (5) status of the drug as a follow-on to previously approved drugs,
(continued...)
Sponsored by: Sen. Jack Reed
Read Twice And Referred To The Committee On Finance. on 02/09/2017
Spread the world
US Congress 115th Congress
Opioid Abuse Prevention and Treatment Act of 2017 [HB-993]
Opioid Abuse Prevention and Treatment Act of 2017 This bill requires the Department of Health and Human Services (HHS) to award grants to states to develop a peer review process to identify and investigate questionable or inappropriate prescribing and dispensing patterns of drugs classified as schedule II or III under the Controlled Substances Act, which are drugs with an accepted medical use that have the potential to be abused and addictive. This bill amends the Public Health Service Act to require HHS to establish grant programs to: (1) facilitate
(continued...)
Sponsored by: Rep. Sean Maloney
Referred To The Subcommittee On Health. on 02/10/2017
Spread the world
US Congress 115th Congress
Personal Drug Importation Fairness Act of 2017 [HB-934]
Personal Drug Importation Fairness Act of 2017 This bill allows a drug to be imported by a person other than the drug's manufacturer if the drug: (1) has the same active ingredients, route of administration, and strength as an approved drug; (2) may be lawfully marketed in, and is imported or reimported from, a country included on a list in this Act that the Food and Drug Administration determines has standards for ensuring drug safety and effectiveness that are at least as protective as U.S. standards; (3) is dispensed by a licensed pharmacist;
(continued...)
Sponsored by: Rep. Keith Ellison
Referred To The Subcommittee On Health. on 02/10/2017
Spread the world
US Congress 115th Congress
Right to Try Act of 2017 [HB-878]
Right to Try Act of 2017 This bill requires the federal government to allow unrestricted manufacturing, distribution, prescribing, and dispensing of experimental drugs, biological products, and medical devices that are: (1) intended to treat a patient who has been diagnosed with a terminal illness, and (2) authorized by state law. The federal government must allow unrestricted possession and use of such treatments by patients certified by a physician as having exhausted all other treatment options. A manufacturer, distributor, prescriber, dispenser,
(continued...)
Sponsored by: Rep. Alexander Mooney
Referred To The Subcommittee On The Constitution And Civil Justice. on 03/02/2017
Spread the world
US Congress 115th Congress
Increasing Competition in Pharmaceuticals Act [S.297]
Increasing Competition in Pharmaceuticals Act This bill amends the Federal Food, Drug, and Cosmetic Act to revise provisions regarding review and approval of generic drug applications or supplements to generic drug applications for drugs: (1) for which there is a shortage, or (2) that have not been recently introduced to the market by more than one manufacturer and for which tentative approval has not been granted to more than two applications. The Food and Drug Administration (FDA) must prioritize the review of such submissions and act on them
(continued...)
Sponsored by: Sen. Susan Collins
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 02/02/2017